<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03911960</url>
  </required_header>
  <id_info>
    <org_study_id>1R03DA043596-01A1</org_study_id>
    <nct_id>NCT03911960</nct_id>
  </id_info>
  <brief_title>Acceptance and Commitment Therapy for Tobacco Cessation Among Psychiatric Partial Hospital Patients</brief_title>
  <official_title>Acceptance and Commitment Therapy for Tobacco Cessation Initiated in a Psychiatric Partial Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Miriam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Miriam Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      People with serious mental illness are three times more likely to smoke cigarettes than&#xD;
      people without mental illness. People with mental illness are less likely to be successful in&#xD;
      quitting smoking than those without mental illness. Therefore, the healthcare community needs&#xD;
      to find ways to get people with mental illness treatment to help them stop smoking. This&#xD;
      study explores whether a treatment, called acceptance and commitment therapy, which is an&#xD;
      affective therapy for serious mental illness, can help patients with serious mental illness&#xD;
      stop smoking. In particular, the investigators test whether patients will be interested in&#xD;
      receiving acceptance and commitment therapy for smoking cessation in a psychiatric partial&#xD;
      hospital (also known as a day treatment program), whether they are able to complete the&#xD;
      treatment, and whether it will help them stop smoking compared to usual care. To test these&#xD;
      research questions, 40 patients in the Rhode Island Hospital's psychiatric partial hospital&#xD;
      will be recruited. Half of the patients will receive acceptance and commitment therapy to&#xD;
      help them stop smoking (2 in person sessions, 5 telephone sessions) and half will receive&#xD;
      usual care (2 in person sessions, electronic referral to the Rhode Island tobacco quit line).&#xD;
      All participants will be offered the nicotine patch. All participants will complete a&#xD;
      baseline survey and a follow-up visit at the end of treatment to measure whether they stopped&#xD;
      smoking and whether they liked the treatment. The study will also measure how many&#xD;
      participants completed the treatment sessions. If successful, this treatment model could be a&#xD;
      way to get more patients with mental illness into treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: There is a significant disparity in tobacco use in that smokers with mental&#xD;
      illness smoke at twice the rate of the general population, use more tobacco per day and are&#xD;
      disproportionately affected by smoking-related disease. Few models exist for treating tobacco&#xD;
      use in individuals with mental illness. Acceptance and Commitment Therapy (ACT) is a&#xD;
      treatment strategy that helps individuals accept discomfort while making value-guided change.&#xD;
      It has been used successfully to treat psychiatric symptoms in people with serious mental&#xD;
      illness (SMI) and is well-suited to treat smoking in people with SMI. Psychiatric partial&#xD;
      hospitalization programs provide an opportunity to intervene on tobacco use in people with&#xD;
      SMI. OBJECTIVE: This study tests the feasibility of offering an ACT-based smoking cessation&#xD;
      treatment initiated in a psychiatric partial hospital program and continuing post-discharge.&#xD;
      AIMS: The study has 3 aims: (1) To assess the feasibility, acceptability, and safety of an&#xD;
      ACT-based, partial hospital initiated, counseling intervention for smoking cessation. (2) To&#xD;
      collect preliminary evidence of the efficacy (i.e., effect size estimates) of ACT-based&#xD;
      counseling initiated in the partial hospital compared to usual care. (3) To explore of the&#xD;
      effect of treatment condition (ACT vs. Usual Care) on ACT treatment targets. DESIGN: This&#xD;
      study is a randomized design (n=40), where patients in an ACT-based psychiatric partial&#xD;
      hospital will be offered up to 8 weeks of the nicotine patch and randomly assigned to either&#xD;
      ACT care (n=20; two in-person ACT-based counseling sessions + 5 ACT-based telephone&#xD;
      counseling sessions) or to Enhanced Usual Care (n=20; two in person medication management&#xD;
      counseling sessions + referral to the state quit line). Outcomes assessed at end of treatment&#xD;
      include: feasibility (percent of eligible patients who enroll, percent of patients completing&#xD;
      treatment), acceptability (patient satisfaction ratings), safety (hospital readmissions,&#xD;
      symptom exacerbation), efficacy (CO confirmed 7 day point prevalence abstinence at end of&#xD;
      treatment) and ACT treatment targets (tolerance of discomfort, mindfulness and acceptance).&#xD;
      SIGNIFICANCE: This study tests a treatment model for smokers with SMI, a group with&#xD;
      particularly refractory smoking behavior. If successful, this model could be implemented&#xD;
      broadly in psychiatric day treatment programs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Actual">November 15, 2019</completion_date>
  <primary_completion_date type="Actual">November 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of Recruitment: Proportion of Smokers Seen During the Partial Hospital Visit Who Enroll in the Study</measure>
    <time_frame>Through study completion, approximately 5 months.</time_frame>
    <description>proportion of smokers seen during the partial hospital visit who enroll in the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Counseling Sessions Completed</measure>
    <time_frame>through study completion, an average of 7 weeks.</time_frame>
    <description>number of scheduled counseling sessions completed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Client Satisfaction Questionnaire</measure>
    <time_frame>at study completion, an average of 7 weeks post-enrollment</time_frame>
    <description>The Client satisfaction Questionnaire, measures acceptability of the intervention to patients, minimum value=8, maximum value=32, higher scores indicate higher satisfaction (higher scores mean better outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Are Rehospitalized for Psychiatric Reasons</measure>
    <time_frame>At study completion, an average of 7 weeks post enrollment</time_frame>
    <description>This is a simple count based on follow-up survey data of the number of participants who reported being hospitalized for a psychiatric reason following enrollment in the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Are Abstinent From Tobacco</measure>
    <time_frame>at study completion, an average of 7 weeks post enrollment</time_frame>
    <description>a simple count of those who have both a carbon monoxide value consistent with abstinence and self-reported abstinence. Expired carbon monoxide value of less than 6 parts per million was considered abstinent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kessler 6</measure>
    <time_frame>Change between baseline and study completion, 7 weeks post-enrollment</time_frame>
    <description>Kessler 6, global distress measure, minimum value=0, maximum value=24, higher scores = greater distress (worse outcome), this study measures the change in global distress between enrollment and study completion. The change in global distress score minimum value=-24, maximum value=24 (lower scores indicate a better outcome: a reduction in distress)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Avoidance Inflexibility Scale</measure>
    <time_frame>Change between baseline and study completion, 7 weeks post-enrollment</time_frame>
    <description>The avoidance inflexibility scale is a 13-item self-report assessment in which respondents to consider how they respond to difficult thoughts that encourage smoking (e.g., &quot;I need a cigarette&quot;, &quot;I wish I could have a cigarette now!&quot;), different feelings that encourage smoking (e.g., stress, fatigue, boredom, enjoyment, satisfaction, etc.), and bodily sensations that encourage smoking (e.g., &quot;physical cravings or withdrawal symptoms&quot;).The Avoidance Inflexibility Scale measures smoking-related experiential avoidance, minimum score= 13, maximum score=65, higher score indicate more avoidance (worse outcome), the study outcome is the change between avoidance measured at baseline, and at study completion, 7 weeks post-enrollment. Minimum score=-52, maximum score=52 lower scores = better outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Commitment to Quitting Scale</measure>
    <time_frame>Change between baseline and study completion, 7 weeks post-enrollment</time_frame>
    <description>Commitment to Quitting Scale, range 8-40, higher scores indicate greater commitment, commitment will be measured as the change between baseline and study completion, 7 weeks post enrollment.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Tobacco Smoking</condition>
  <condition>Psychiatric Disorder</condition>
  <condition>Psychiatric Hospitalization</condition>
  <arm_group>
    <arm_group_label>Acceptance and Commitment Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Acceptance and Commitment Therapy</intervention_name>
    <description>2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
    <arm_group_label>Acceptance and Commitment Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced Usual Care</intervention_name>
    <description>2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
    <arm_group_label>Enhanced Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants will be male and female&#xD;
&#xD;
          -  psychiatry partial hospital patients&#xD;
&#xD;
          -  current daily smokers&#xD;
&#xD;
             -â‰¥ age 18&#xD;
&#xD;
          -  have regular telephone access&#xD;
&#xD;
          -  able to read and write English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -current use of tobacco cessation treatment (bupropion prescribed for a psychiatric&#xD;
        indication will be permitted)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra Japuntich, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hennepin Healthcare Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ernestine Jennings, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Miriam Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>April 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2019</study_first_posted>
  <results_first_submitted>September 1, 2020</results_first_submitted>
  <results_first_submitted_qc>September 23, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 25, 2020</results_first_posted>
  <last_update_submitted>September 23, 2020</last_update_submitted>
  <last_update_submitted_qc>September 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tobacco smoking</keyword>
  <keyword>psychiatric disorder</keyword>
  <keyword>psychiatric hospitalization</keyword>
  <keyword>acceptance and commitment therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Only the Principal Investigator will give permission for the release of aggregated study data. No identifiable data will be released. Participants in the proposed research will be informed, during consent, that completely de-identified data (i.e., data that has been cleaned of all 18 types of HIPAA identifiers) will be available to other qualified researchers. Within 18 months of study completion, we will make datasets available to interested investigators who submit a written request to the PI. The only contingency on the use of the data will be that ethical guidelines be followed (e.g., only individuals who have completed a research ethics training course will have access to the data, the data will be stored securely). The NIH will be notified of transmissions of the data to interested investigators.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>within 18 months of study completion</ipd_time_frame>
    <ipd_access_criteria>ethical guidelines for The Miriam Hospital will be followed (the investigator will have completed a research ethics training course and the data will be stored securely)</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03911960/ICF_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03911960/SAP_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 4, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03911960/Prot_003.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>3 participants consented to the study and were randomized but completed none of the study procedures (did not complete the baseline questionnaire, any of the counseling sessions, or the follow-up visit).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Acceptance and Commitment Therapy</title>
          <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
        </group>
        <group group_id="P2">
          <title>Enhanced Usual Care</title>
          <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acceptance and Commitment Therapy</title>
          <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
        </group>
        <group group_id="B2">
          <title>Enhanced Usual Care</title>
          <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.33" spread="17.30"/>
                    <measurement group_id="B2" value="34.00" spread="12.39"/>
                    <measurement group_id="B3" value="38.71" spread="15.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Feasibility of Recruitment: Proportion of Smokers Seen During the Partial Hospital Visit Who Enroll in the Study</title>
        <description>proportion of smokers seen during the partial hospital visit who enroll in the study</description>
        <time_frame>Through study completion, approximately 5 months.</time_frame>
        <population>This analysis calculates the number of smokers screened in the partial hospitalization program who participated in the trial</population>
        <group_list>
          <group group_id="O1">
            <title>All Participants</title>
            <description>This outcome assesses interest in the trial prior to randomization.</description>
          </group>
        </group_list>
        <measure>
          <title>Feasibility of Recruitment: Proportion of Smokers Seen During the Partial Hospital Visit Who Enroll in the Study</title>
          <description>proportion of smokers seen during the partial hospital visit who enroll in the study</description>
          <population>This analysis calculates the number of smokers screened in the partial hospitalization program who participated in the trial</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Counseling Sessions Completed</title>
        <description>number of scheduled counseling sessions completed</description>
        <time_frame>through study completion, an average of 7 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acceptance and Commitment Therapy</title>
            <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Usual Care</title>
            <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Counseling Sessions Completed</title>
          <description>number of scheduled counseling sessions completed</description>
          <units>percentage of sessions completed</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Client Satisfaction Questionnaire</title>
        <description>The Client satisfaction Questionnaire, measures acceptability of the intervention to patients, minimum value=8, maximum value=32, higher scores indicate higher satisfaction (higher scores mean better outcome)</description>
        <time_frame>at study completion, an average of 7 weeks post-enrollment</time_frame>
        <population>participants who completed the follow-up questionnaire</population>
        <group_list>
          <group group_id="O1">
            <title>Acceptance and Commitment Therapy</title>
            <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Usual Care</title>
            <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
          </group>
        </group_list>
        <measure>
          <title>Client Satisfaction Questionnaire</title>
          <description>The Client satisfaction Questionnaire, measures acceptability of the intervention to patients, minimum value=8, maximum value=32, higher scores indicate higher satisfaction (higher scores mean better outcome)</description>
          <population>participants who completed the follow-up questionnaire</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.00" spread="6.63"/>
                    <measurement group_id="O2" value="27.5" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Are Rehospitalized for Psychiatric Reasons</title>
        <description>This is a simple count based on follow-up survey data of the number of participants who reported being hospitalized for a psychiatric reason following enrollment in the study.</description>
        <time_frame>At study completion, an average of 7 weeks post enrollment</time_frame>
        <population>participants who completed the follow-up survey</population>
        <group_list>
          <group group_id="O1">
            <title>Acceptance and Commitment Therapy</title>
            <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Usual Care</title>
            <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Are Rehospitalized for Psychiatric Reasons</title>
          <description>This is a simple count based on follow-up survey data of the number of participants who reported being hospitalized for a psychiatric reason following enrollment in the study.</description>
          <population>participants who completed the follow-up survey</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Are Abstinent From Tobacco</title>
        <description>a simple count of those who have both a carbon monoxide value consistent with abstinence and self-reported abstinence. Expired carbon monoxide value of less than 6 parts per million was considered abstinent.</description>
        <time_frame>at study completion, an average of 7 weeks post enrollment</time_frame>
        <population>all participants who started the intervention</population>
        <group_list>
          <group group_id="O1">
            <title>Acceptance and Commitment Therapy</title>
            <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Usual Care</title>
            <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Are Abstinent From Tobacco</title>
          <description>a simple count of those who have both a carbon monoxide value consistent with abstinence and self-reported abstinence. Expired carbon monoxide value of less than 6 parts per million was considered abstinent.</description>
          <population>all participants who started the intervention</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Kessler 6</title>
        <description>Kessler 6, global distress measure, minimum value=0, maximum value=24, higher scores = greater distress (worse outcome), this study measures the change in global distress between enrollment and study completion. The change in global distress score minimum value=-24, maximum value=24 (lower scores indicate a better outcome: a reduction in distress)</description>
        <time_frame>Change between baseline and study completion, 7 weeks post-enrollment</time_frame>
        <population>participants who completed follow-up assessment</population>
        <group_list>
          <group group_id="O1">
            <title>Acceptance and Commitment Therapy</title>
            <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Usual Care</title>
            <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
          </group>
        </group_list>
        <measure>
          <title>Kessler 6</title>
          <description>Kessler 6, global distress measure, minimum value=0, maximum value=24, higher scores = greater distress (worse outcome), this study measures the change in global distress between enrollment and study completion. The change in global distress score minimum value=-24, maximum value=24 (lower scores indicate a better outcome: a reduction in distress)</description>
          <population>participants who completed follow-up assessment</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.25" spread="7.59"/>
                    <measurement group_id="O2" value="-5.0" spread="7.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Avoidance Inflexibility Scale</title>
        <description>The avoidance inflexibility scale is a 13-item self-report assessment in which respondents to consider how they respond to difficult thoughts that encourage smoking (e.g., &quot;I need a cigarette&quot;, &quot;I wish I could have a cigarette now!&quot;), different feelings that encourage smoking (e.g., stress, fatigue, boredom, enjoyment, satisfaction, etc.), and bodily sensations that encourage smoking (e.g., &quot;physical cravings or withdrawal symptoms&quot;).The Avoidance Inflexibility Scale measures smoking-related experiential avoidance, minimum score= 13, maximum score=65, higher score indicate more avoidance (worse outcome), the study outcome is the change between avoidance measured at baseline, and at study completion, 7 weeks post-enrollment. Minimum score=-52, maximum score=52 lower scores = better outcome.</description>
        <time_frame>Change between baseline and study completion, 7 weeks post-enrollment</time_frame>
        <population>people who completed follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Acceptance and Commitment Therapy</title>
            <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Usual Care</title>
            <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
          </group>
        </group_list>
        <measure>
          <title>Avoidance Inflexibility Scale</title>
          <description>The avoidance inflexibility scale is a 13-item self-report assessment in which respondents to consider how they respond to difficult thoughts that encourage smoking (e.g., &quot;I need a cigarette&quot;, &quot;I wish I could have a cigarette now!&quot;), different feelings that encourage smoking (e.g., stress, fatigue, boredom, enjoyment, satisfaction, etc.), and bodily sensations that encourage smoking (e.g., &quot;physical cravings or withdrawal symptoms&quot;).The Avoidance Inflexibility Scale measures smoking-related experiential avoidance, minimum score= 13, maximum score=65, higher score indicate more avoidance (worse outcome), the study outcome is the change between avoidance measured at baseline, and at study completion, 7 weeks post-enrollment. Minimum score=-52, maximum score=52 lower scores = better outcome.</description>
          <population>people who completed follow-up</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.25" spread="15.69"/>
                    <measurement group_id="O2" value="6.5" spread="6.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Commitment to Quitting Scale</title>
        <description>Commitment to Quitting Scale, range 8-40, higher scores indicate greater commitment, commitment will be measured as the change between baseline and study completion, 7 weeks post enrollment.</description>
        <time_frame>Change between baseline and study completion, 7 weeks post-enrollment</time_frame>
        <population>participants who completed the follow-up survey</population>
        <group_list>
          <group group_id="O1">
            <title>Acceptance and Commitment Therapy</title>
            <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Usual Care</title>
            <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
          </group>
        </group_list>
        <measure>
          <title>Commitment to Quitting Scale</title>
          <description>Commitment to Quitting Scale, range 8-40, higher scores indicate greater commitment, commitment will be measured as the change between baseline and study completion, 7 weeks post enrollment.</description>
          <population>participants who completed the follow-up survey</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.25" spread="7.63"/>
                    <measurement group_id="O2" value="4.5" spread="4.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>5 weeks (from enrollment to follow-up)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acceptance and Commitment Therapy</title>
          <description>2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.&#xD;
Acceptance and Commitment Therapy: 2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch</description>
        </group>
        <group group_id="E2">
          <title>Enhanced Usual Care</title>
          <description>2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch&#xD;
Enhanced Usual Care: 2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sandra Japuntich</name_or_title>
      <organization>Hennepin Healthcare</organization>
      <phone>6128736856</phone>
      <email>sandra.japuntich@hcmed.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

